Gene · 4940
Papers2,054
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,054
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SARS-CoV-2 ORF8: A Rapidly Evolving Immune and Viral Modulator in COVID-19. | Viruses | 2023 | 37112851 | PubTator, text mining | PubMed |
| Effect of Rotavirus Infection and 2'-Fucosyllactose Administration on Rat Intestinal Gene Expression. | Nutrients | 2023 | 37111215 | PubTator, text mining | PubMed |
| Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing. | Int J Mol Sci | 2023 | 37108564 | PubTator, text mining | PubMed |
| Pharmaco-Omics in Psoriasis: Paving the Way towards Personalized Medicine. | Int J Mol Sci | 2023 | 37108251 | PubTator, text mining | PubMed |
| Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation. | Leukemia | 2023 | 37100883 | PubTator, text mining | PubMed |
| Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS). | Pediatr Rheumatol Online J | 2023 | 37087470 | PubTator, text mining | PubMed |
| Transcriptomics unravels molecular changes associated with cilia and COVID-19 in chronic rhinosinusitis with nasal polyps. | Sci Rep | 2023 | 37085563 | PubTator, text mining | PubMed |
| Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progression. | Transl Oncol | 2023 | 37068401 | PubTator, text mining | PubMed |
| Tissue-like environments shape functional interactions of HIV-1 with immature dendritic cells. | EMBO Rep | 2023 | 37042686 | PubTator, text mining | PubMed |
| Stress granules are shock absorbers that prevent excessive innate immune responses to dsRNA. | Mol Cell | 2023 | 37028415 | PubTator, text mining | PubMed |
| Comprehensive Explorations of CCL28 in Lung Adenocarcinoma Immunotherapy and Experimental Validation. | J Inflamm Res | 2023 | 37006812 | PubTator, text mining | PubMed |
| SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells. | Mol Cell Proteomics | 2023 | 37001587 | PubTator, text mining | PubMed |
| A single-cell atlas reveals shared and distinct immune responses and metabolic profiles in SARS-CoV-2 and HIV-1 infections. | Front Genet | 2023 | 36992700 | PubTator, text mining | PubMed |
| Hepatitis C virus fitness can influence the extent of infection-mediated epigenetic modifications in the host cells. | Front Cell Infect Microbiol | 2023 | 36992689 | PubTator, text mining | PubMed |
| Characterization of Live-Attenuated Powassan Virus Vaccine Candidates Identifies an Efficacious Prime-Boost Strategy for Mitigating Powassan Virus Disease in a Murine Model. | Vaccines (Basel) | 2023 | 36992196 | PubTator, text mining | PubMed |
| Optimal Selection of IFN-α-Inducible Genes to Determine Type I Interferon Signature Improves the Diagnosis of Systemic Lupus Erythematosus. | Biomedicines | 2023 | 36979843 | PubTator, text mining | PubMed |
| Role of OAS gene family in COVID-19 induced heart failure. | J Transl Med | 2023 | 36949448 | PubTator, text mining | PubMed |
| Corticosteroids reduce pathologic interferon responses by downregulating STAT1 in patients with high-risk COVID-19. | Exp Mol Med | 2023 | 36941461 | PubTator, text mining | PubMed |
| Genetic susceptibility to severe COVID-19. | Infect Genet Evol | 2023 | 36934789 | PubTator, text mining | PubMed |
| Co-expression and interaction network analysis reveals dysregulated neutrophil and T-cell activation as the core mechanism associated with septic shock. | Front Genet | 2023 | 36911395 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4940/papers?page=15